Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - diclofenac sodium, quantity: 50 mg - tablet, enteric coated - excipient ingredients: microcrystalline cellulose; macrogol 8000; purified talc; iron oxide red; colloidal anhydrous silica; iron oxide yellow; lactose monohydrate; magnesium stearate; povidone; titanium dioxide; peg-40 hydrogenated castor oil; hypromellose; sodium starch glycollate; methacrylic acid copolymer; maize starch; simethicone; sorbic acid; steareth-2 - inflammatory and degenerative forms of rheumatism: rheumatoid arthritis and osteoarthritis. relief of acute or chronic pain states in which there is an inflammatory component. symptomatic treatment of primary dysmenorrhoea

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - diclofenac sodium, quantity: 25 mg - tablet, enteric coated - excipient ingredients: macrogol 8000; iron oxide yellow; peg-40 hydrogenated castor oil; acrylates copolymer; maize starch; sodium starch glycollate; purified talc; colloidal anhydrous silica; microcrystalline cellulose; hypromellose; magnesium stearate; povidone; lactose monohydrate; titanium dioxide; simethicone; sorbic acid; steareth-2 - inflammatory and degenerative forms of rheumatism: rheumatoid arthritis and osteoarthritis. relief of acute or chronic pain states in which there is an inflammatory component. symptomatic treatment of primary dysmenorrhoea.

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - diclofenac sodium, quantity: 50 mg - suppository, moulded - excipient ingredients: hydrogenated coco-glycerides; hard fat - inflammatory and degenerative forms of rheumatism: rheumatoid arthritis and osteoarthritis. short term (up to three days) treatment of post-operative pain in children.

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - diclofenac sodium, quantity: 25 mg - suppository, moulded - excipient ingredients: hydrogenated coco-glycerides; hard fat - inflammatory and degenerative forms of rheumatism: rheumatoid arthritis and osteoarthritis. short term (up to three days) treatment of post-operative pain in children.

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - diclofenac sodium, quantity: 12.5 mg - suppository, moulded - excipient ingredients: hydrogenated coco-glycerides; hard fat - inflammatory and degenerative forms of rheumatism: rheumatoid arthritis and osteoarthritis. short term (up to three days) treatment of post-operative pain in children.

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - diclofenac sodium, quantity: 100 mg - suppository, moulded - excipient ingredients: - inflammatory and degenerative forms of rheumatism: rheumatoid arthritis and osteoarthritis. short term (up to three days) treatment of post-operative pain in children.

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - diclofenac sodium -

Malta - English - Medicines Authority

novartis ireland limited vista building, elm park, merrion road, ballsbridge, dublin 4,, ireland - diclofenac sodium - suppository - diclofenac sodium 50 mg - antiinflammatory and antirheumatic products

Malta - English - Medicines Authority

novartis ireland limited vista building, elm park, merrion road, ballsbridge, dublin 4,, ireland - diclofenac sodium - suppository - diclofenac sodium 12.5 mg - antiinflammatory and antirheumatic products

Malta - English - Medicines Authority

novartis ireland limited vista building, elm park, merrion road, ballsbridge, dublin 4,, ireland - diclofenac sodium - suppository - diclofenac sodium 100 mg - antiinflammatory and antirheumatic products